Holen Sie sich die Stockscreener-App
19.88
3.40%
-0.70
Handel nachbörslich:
19.72
-0.16
-0.80%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$20.58
Offen:
$20.14
24-Stunden-Volumen:
2.13M
Relative Volume:
1.44
Marktkapitalisierung:
$3.03B
Einnahmen:
$5.84B
Nettoeinkommen (Verlust:
$-330.00M
KGV:
-9.8905
EPS:
-2.01
Netto-Cashflow:
$9.00M
1W Leistung:
+8.69%
1M Leistung:
+1.58%
6M Leistung:
-25.18%
1J Leistung:
-22.59%
1-Tages-Spanne:
$19.70
$20.45
1-Wochen-Bereich:
$17.64
$21.25
52-Wochen-Spanne:
$15.10
$32.70
Chemours Company Stock (CC) Company Profile
Firmenname
Chemours Company
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Chemours Company Stock (CC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-24 | Hochstufung | UBS | Neutral → Buy |
| 2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-13 | Eingeleitet | Goldman | Neutral |
| 2022-10-05 | Herabstufung | Argus | Buy → Hold |
| 2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-20 | Eingeleitet | BofA Securities | Buy |
| 2021-05-06 | Hochstufung | Argus | Hold → Buy |
| 2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
| 2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
| 2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
| 2019-11-06 | Hochstufung | CFRA | Hold → Buy |
| 2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | Herabstufung | Argus | Buy → Hold |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
| 2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
| 2019-01-08 | Eingeleitet | HSBC Securities | Buy |
| 2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
| 2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Chemours Company Aktie (CC) Neueste Nachrichten
Chemours (NYSE:CC) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Chemours (NYSE:CC) Stock Price - MarketBeat
Chemours (NYSE:CC) Price Target Raised to $23.00 - MarketBeat
What Analysts Are Saying About Chemours Stock - Benzinga
The Chemours Company (NYSE:CC) Q3 2024 Earnings Call Transcript - Insider Monkey
Chemours price target lowered to $25 from $30 at Morgan Stanley - TipRanks
Chemours Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Chemours price target raised to $23 from $21 at Barclays - TipRanks
Should You Investigate The Chemours Company (NYSE:CC) At US$20.58? - Yahoo Finance
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
The Chemours Co (CC) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Chemours Reports Q3 2024 Results and Strategic Update - TipRanks
Chemours (CC) Stabilizes with Strong Q3 Results and Record Sales in TSS Segment - GuruFocus.com
Chemours (CC) Q3 2024 Earnings Call Transcript - The Motley Fool
Chemours (NYSE:CC) Shares Gap UpWhat's Next? - MarketBeat
The Chemours Co (CC) Stock Price Up 16.44% on Nov 4 - GuruFocus.com
Chemours Washington Works Nature Trail Dedicates Outdoor Classroom to U.S. Senator Joe Manchin, III - 3BL Media
Update: Chemours halts $200m hydrogen membrane manufacturing expansion - H2 View
Chemours's stock jumps on quarterly revenue growth (NYSE:CC) - Seeking Alpha
Chemours Surges 17% On The Recent Q3 Results - GuruFocus.com
Chemours Adjusts Hydrogen Investment Strategy Amid Market Slowdown - FuelCellsWorks
Chemours (CC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Chemours's stock jumps on quarterly revenue growth - MSN
CCThe Chemours Company Latest Stock News & Market Updates - StockTitan
Chemours Swings to 3Q Loss But Sales Grow, Beating Market Views - MarketWatch
Chemours (CC) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Chemours Co earnings beat by $0.11, revenue topped estimates - Investing.com
Chemours: Q3 Earnings Snapshot - The Advocate
Chemours sees Q4 revenue down in the mid to high-single digits sequentially - TipRanks
Chemours stock rises as Q3 earnings and revenue top estimates - Investing.com India
The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy - The Bakersfield Californian
The Chemours Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Chemours Co (FRA:2CU) Intrinsic Value: Projected FCF : €16.16 (As of Nov. 03, 2024) - GuruFocus.com
Private Management Group Inc. Purchases 329,037 Shares of The Chemours Company (NYSE:CC) - MarketBeat
Can The Chemours Company's (NYSE:CC) ROE Continue To Surpass The Industry Average? - Simply Wall St
How to Take Advantage of moves in (CC) - Stock Traders Daily
The Chemours Co (LTS:0HWG) Earnings Yield % : 4.12% (As of Oct. 30, 2024) - GuruFocus.com
Long-Term Investors in Chemours Company (NYSE: CC) shares - openPR
Nafion Market Is Booming So Rapidly | Chemours, 3M, Dongyue Group - openPR
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline - Yahoo Finance
Europe Refrigerant Market: Size, Share, Demand, Trends, - openPR
Chemours (CC) Set to Announce Earnings on Monday - MarketBeat
Chemours cuts ribbon on new polymer production line - MSN
THE CHEMOURS COMPANY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Chemours CompanyCC - Business Wire
Process Technology Spring InternshipThe Chemours Company - Built In
Mining Engineer Summer InternThe Chemours Company - Built In
The Chemours Company (NYSE:CC) Declares Quarterly Dividend of $0.25 - MarketBeat
Fluoropolymers Market Report: Research Insights and Growth - openPR
Chemours Washington Works facility is expanding production - WTAP
Chemours Announces Fourth Quarter Dividend - The Bakersfield Californian
State sets temporary allowable PFAS limits in groundwater - NC Newsline
Finanzdaten der Chemours Company-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):